Finally, PERK pathway expression also correlated to differentiation state and overall survival in invasive high-grade glioma—tumors stratified into a PERK-high group were almost exclusively poorly differentiated grade 4 GBM and had significantly worse overall survival than the PERK-low group (Figure 5i,j). The gene discussed is EIF2AK3; the disease is central nervous system cancer.